HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

INOD

Innodata Inc. (NASDAQ)

Technology — Information Technology Services

Innodata Inc. operates as a data engineering company in the United States, the United Kingdom, the Netherlands, Canada, Germany, Belgium, and internationally. The company operates through three segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment engages in the provision of artificial intelligence (AI) training and post-training data, model evaluation, alignment, safety, AI model deployment and integration, and AI-enabled platforms. The Synodex segment offers an industry platform that transforms medical records into structured digital data for insurance and healthcare workflows. The company also provides Agility PR Solutions platform that provides media intelligence and public relations workflow software enhanced with AI-driven monitoring, analytics, and content capabilities. It serves banking, insurance, financial services, technology, digital retailing, and information media sectors through its professional staff, senior management, and direct sales personnel. The company was formerly known as Innodata Isogen Inc. and changed its name to Innodata Inc. in November 2003. Innodata Inc. was incorporated in 1988 and is headquartered in Ridgefield Park, New Jersey.

None 4 analysts
$72.23
$-3.35 (-4.43%)
Target: $122.75 (69.9%)
Sign in to add INOD to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$2.36B
P/E Ratio (TTM)64.49
Forward P/E36.12
EPS (TTM)$1.12
Dividend Yield-
Profit Margin13.86%
Revenue Growth54.40%
ROE38.60%
Debt/Equity3.20
Recommendation None
Analyst Target$122.75
Analysts4
Indexes NASDAQ

Technical Indicators

RSI (14)27.3
Beta2.84
SMA 20-
SMA 40-
52-Week High$125.14
52-Week Low$34.23
50-Day Avg$81.91
200-Day Avg$63.44
Avg Volume$1.96M
Volume$1.63M

Performance Analysis

BULLISH

INOD shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 42% of its 52-week range.
+ RSI at 27.3 signals oversold conditions — a bounce may be ahead.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
- P/E of 64.5 is elevated — the market expects high growth or it may be overvalued.
+ Strong revenue growth of 54.4% year-over-year.
~ Wall Street consensus is "none" from 4 analysts.
+ Average analyst target of $122.75 implies 69.9% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:15 UTC

Back to Screener Export Report